Insulet Corp (PODD) Reports Executive & Director Changes

Ticker: PODD · Form: 8-K · Filed: 2025-03-17T00:00:00.000Z

Sentiment: neutral

Topics: executive-changes, board-changes, compensation

Related Tickers: PODD

TL;DR

PODD filed an 8-K for exec/director changes and comp updates. Keep an eye on who's in/out.

AI Summary

On March 14, 2025, Insulet Corporation filed an 8-K report detailing changes in its executive officers and board of directors. The filing indicates a departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for key personnel. Specific details regarding the individuals involved and the exact nature of the compensatory changes were not fully elaborated in the provided text.

Why It Matters

Changes in executive leadership and board composition can signal shifts in company strategy, governance, or future performance, impacting investor confidence and stock valuation.

Risk Assessment

Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and leadership stability.

Key Players & Entities

FAQ

What specific executive positions have seen departures?

The filing indicates the 'Departure of Directors or Certain Officers' but does not specify which particular officers have departed in the provided text.

Who are the newly elected directors?

The filing mentions the 'Election of Directors' but does not list the names of the newly elected directors in the provided text.

What are the details of the compensatory arrangements for certain officers?

The filing notes 'Compensatory Arrangements of Certain Officers' but does not provide specific details on these arrangements in the provided text.

What is the exact date of the earliest event reported in this 8-K?

The earliest event reported is dated March 14, 2025.

What is Insulet Corporation's state of incorporation?

Insulet Corporation is incorporated in Delaware.

From the Filing

0001145197-25-000014.txt : 20250317 0001145197-25-000014.hdr.sgml : 20250317 20250317170607 ACCESSION NUMBER: 0001145197-25-000014 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250314 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250317 DATE AS OF CHANGE: 20250317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 25745507 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 podd-20250314.htm 8-K podd-20250314 0001145197 FALSE 0001145197 2025-03-14 2025-03-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):  March 14, 2025   INSULET CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-33462 04-3523891 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 100 Nagog Park Acton Massachusetts 01720 (Address of Principal Executive Offices, including Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter) Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share PODD The NASDAQ Stock Market, LLC Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Mark Field, Senior Vice President, Chief Technology Officer of Insulet Corporation (the “ Company ”) left the Company to pursue other opportunities, effective March 14, 2025. As the Company initiates a search for a new Chief Technology Officer, Amit Guliani, currently serving as Group Vice President, Software Engineering, will serve as acting Chief Technology Officer, effective immediately. Mr. Field will receive standard severance benefits under the Company’s Amended and Restated Executive Severance Plan. In addition, the Company intends to enter into a Consulting Agreement with Mr. Field to facilitate a smooth transition. In the eve

View on Read The Filing